Double-stranded DNA minor groove (guanine-containing triplets)

The double-stranded DNA (dsDNA) minor groove at guanine-containing triplets is a specific structural region of the DNA double helix that serves as a target for various small-molecule ligands. This site is characterized by a unique pattern of hydrogen bond donors and acceptors that allow for the selective binding of aureolic acid antibiotics, such as Mithramycin (Plicamycin) and Chromomycin A3 (PubMed, PMID: 21533185). These drugs typically bind as dimers in the presence of divalent cations like magnesium, specifically targeting GC-rich sequences such as 5'-GGC-3' or 5'-GGG-3' (Nucleic Acids Research, 1997). The primary biological effect of this interaction is the steric displacement of transcription factors, most notably the Sp1 family, which require these GC-rich motifs for DNA recognition and binding (Journal of Biological Chemistry, 1991). By inhibiting the binding of these factors, minor groove binders can potently suppress the transcription of oncogenes and other genes critical for cell survival and proliferation. Clinically, this target has been utilized in the treatment of certain malignancies and hypercalcemia, although its therapeutic utility is often limited by significant systemic toxicities (StatPearls). These toxicities include severe hemorrhagic syndromes and organ damage, resulting from the relatively broad impact on gene expression across different tissues. Consequently, research continues into the development of synthetic polyamides and other sequence-specific ligands to improve the safety and efficacy of targeting the DNA minor groove.

Other names

GC-rich DNA minor grooveGuanine-rich DNA sequencesDNA minor groove (GC-specific)Aureolic acid binding site

Binding to the minor groove of GC-rich DNA sequences, often mediated by divalent cations, to sterically inhibit the binding of transcription factors like Sp1 and prevent RNA polymerase progression.